Catalent, Inc. - CTLT

SEC Filings Our CTLT Tweets

About Gravity Analytica

Recent News

  • 07.27.2026 - The CEO Magazine
  • 07.27.2026 - KoNECT MOHW MFDS International Conference 2026
  • 07.27.2026 - PBSS Orally Bioavailable Peptides Oct 2026
  • 07.27.2026 - NLS Days 2026
  • 07.27.2026 - 17th Annual World Bispecific Summit 2026
  • 07.27.2026 - Bioprocessing Summit US 2026
  • 07.27.2026 - Boulder Peptide Symposium 2026
  • 07.27.2026 - University Parma Future of Inhalation 2026
  • 07.23.2026 - AAPS PharmSci 360 2026
  • 07.07.2026 - Catalent and Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of MCO-010

Recent Filings

  • 12.30.2024 - 15-12G Securities registration termination [Section 12(g)]
  • 12.18.2024 - 8-K Current report
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities